COMMUNIQUÉS West-GlobeNewswire

Share Capital and Votes

28/11/2018 - 13:47

November 28, 2018 Announcement no. 24 Share Capital and Votes Pursuant to section 32 of the Danish Capital Markets Act, it is hereby announced, that BioPorto A/S’ total share capital amounts to DKK 165,687,798 divided [...]

Moleculin Announces New Data Further Supporting Its Lead Drug for Treating Pancreatic Cancer

28/11/2018 - 13:30

WP1732 shown to accumulate beneficially in pancreas HOUSTON, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on [...]

Alliqua BioMedical to spin off and merge its Contract Manufacturing Business with TO Pharmaceuticals LLC to Create an Independent, Publicly Traded Company focused on Cannabinoid-Based Pharmaceutical Therapies

28/11/2018 - 13:30

LANGHORNE, Pa., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA) and TO Pharmaceuticals LLC, a privately held cannabinoid-based pharmaceutical therapy company (“TOP”), today announced plans for [...]

Kura Oncology Announces New Patent for Tipifarnib in Angioimmunoblastic T-Cell Lymphoma

28/11/2018 - 13:30

– AITL patent expands protection for tipifarnib, provides exclusivity in U.S. to 2037 – – Prospective data from AITL and CXCL12+ cohorts in Phase 2 trial of tipifarnib in PTCL upcoming at ASH 2018 – SAN DIEGO, Nov. 28, [...]

Orion Corporation: Managers' transactions - Agendum Oy

28/11/2018 - 13:16

ORION CORPORATION MANAGERS' TRANSACTIONS 28 November 2018 at 14.15 EET Orion Corporation: Managers' transactions - Agendum Oy Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]

Epistem completes board line up and launches new NGS service

28/11/2018 - 13:00

MANCHESTER, United Kingdom, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Epistem Limited , the Manchester based pre-clinical and clinical research services company announces the completion of its Board appointments. Benjamin Reed [...]

Aclaris Therapeutics to Attend Upcoming Investor Conferences

28/11/2018 - 13:00

WAYNE, Pa., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]

Emerald Health Therapeutics Announces Executive Chairman Avtar Dhillon Appointed as President; CEO Chris Wagner Steps Down

28/11/2018 - 13:00

VICTORIA, British Columbia, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald” or the “Company”) (TSXV:EMH; OTCQX:EMHTF) announced today that Dr. Avtar Dhillon, Executive Chairman, has been [...]

Medigus Announces Third Quarter 2018 Financial Results

28/11/2018 - 13:00

OMER, Israel, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”) (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and direct visualization [...]

Sunesis Pharmaceuticals to Provide Program Update for Non-Covalent BTK-Inhibitor Vecabrutinib at Analyst & Investor Event during ASH 2018

28/11/2018 - 13:00

-Event on December 2 in San Diego, CA with Slide Webcast- SOUTH SAN FRANCISCO, Calif., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced it will provide a program update for [...]

Share issue / transfer in connection with reduction of the quantity of shares in Nexstim Plc

28/11/2018 - 12:31

Company announcement, Helsinki, 28 November 2018 at 13:30 Share issue / transfer in connection with reduction of the quantity of shares in Nexstim Plc The Extraordinary General Meeting of Nexstim Plc (NXTMH:HEX, NXTMS: [...]

ChromaDex to Present at the 11th Annual LD Micro Main Event

28/11/2018 - 12:30

LOS ANGELES, Nov. 28, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that its Chief Executive Officer, Rob Fried, Co-Founder & Executive Chairman, Frank Jaksch, and Chief Financial Officer, [...]

Affimed to Host Research & Development Day on Friday, December 7, 2018 in New York City

28/11/2018 - 11:00

Heidelberg, Germany, November 28, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies that harness the power of [...]

Invivoscribe soumet le test de mutation LeukoStrat CDx FLT3 à la fois aux États-Unis et au Japon pour soutenir la soumission de Daiichi Sankyo pour le quizartinib

28/11/2018 - 10:53

SAN DIEGO, 28 nov. 2018 (GLOBE NEWSWIRE) -- En soutien à un partenariat en cours avec Daiichi Sankyo, Invivoscribe a le plaisir d’annoncer la soumission du test de mutation LeukoStrat ® CDx FLT3 à la fois à la FDA aux [...]

Aquarius Surgical Technologies Announces Appointment of Mr. Gordon Willox as President & CTO, and the Closing of Funding Transaction

28/11/2018 - 10:00

TORONTO, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Aquarius Surgical Technologies Inc. (ASTI – CSE) (“the Corporation”) is pleased to announce that Mr. Gordon Willox, has been appointed to the position of President and Chief [...]

Olainfarm invites to Third Quarter 2018 Investor Conference Webinar

28/11/2018 - 09:19

JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on December 6, 2018 at 16:00 (EEST). To join the webinar please follow [...]

Sysmex and MolecularMD Commence Global Partnership to Address the Challenges in Companion Diagnostics Development and Commercialization

28/11/2018 - 09:00

To Accelerate Precision Medicine Through Globally Proven Experience PORTLAND, Ore. and CAMBRIDGE, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu), a [...]

INSTI HIV Self Test Earns WHO Prequalification Status for Home Testing

28/11/2018 - 09:00

The newly WHO Prequalified INSTI HIV Self Test makes a mark as it expands into new markets VANCOUVER, British Columbia, Nov. 28, 2018 (GLOBE NEWSWIRE) -- bioLytical Laboratories , a world leader in rapid infectious [...]

B-Temia and Wistron Announce the Incorporation of B-Temia Asia

28/11/2018 - 08:00

B-Temia Asia will launch human mobility device Keeogo(TM) in the Asia Market QUÉBEC CITY, Nov. 28, 2018 (GLOBE NEWSWIRE) -- B-Temia Inc. today announced the official incorporation of B-Temia Asia Pte. Ltd., as a result [...]